These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 3162766

  • 1. Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line.
    Cavard C, Grimber G, Dubois N, Chasse JF, Bennoun M, Minet-Thuriaux M, Kamoun P, Briand P.
    Nucleic Acids Res; 1988 Mar 25; 16(5):2099-110. PubMed ID: 3162766
    [Abstract] [Full Text] [Related]

  • 2. Normalization of hair growth in sparse fur-abnormal skin and hair (SPF-ASH) mice by introduction of the rat ornithine transcarbamylase (OTC) gene.
    Shimada T, Tashiro M, Kanzaki T, Noda T, Murakami T, Takiguchi M, Mori M, Yamamura K, Saheki T.
    J Dermatol Sci; 1994 Jul 25; 7 Suppl():S27-32. PubMed ID: 7999674
    [Abstract] [Full Text] [Related]

  • 3. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP, Bendiks M, Mori M, Kominami E, Robinson MB, Ye X, Wilson JM.
    Mol Med; 1999 Apr 25; 5(4):244-53. PubMed ID: 10448647
    [Abstract] [Full Text] [Related]

  • 4. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K, Kanegae Y, Saito I, Komaki S, Nakamura K, Miyazaki JI, Endo F, Matsuda I.
    Hum Gene Ther; 1996 May 01; 7(7):821-30. PubMed ID: 8860834
    [Abstract] [Full Text] [Related]

  • 5. Importance of ornithine transcarbamylase (OTC) deficiency in small intestine for urinary orotic acid excretion: analysis of OTC-deficient spf-ash mice with OTC transgene.
    Saheki T, Mori K, Kobayashi K, Horiuchi M, Shige T, Obara T, Suzuki S, Mori M, Yamamura K.
    Biochim Biophys Acta; 1995 Jan 25; 1270(1):87-93. PubMed ID: 7827141
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comprehensive characterization of ureagenesis in the spfash mouse, a model of human ornithine transcarbamylase deficiency, reveals age-dependency of ammonia detoxification.
    Allegri G, Deplazes S, Rimann N, Causton B, Scherer T, Leff JW, Diez-Fernandez C, Klimovskaia A, Fingerhut R, Krijt J, Kožich V, Nuoffer JM, Grisch-Chan HM, Thöny B, Häberle J.
    J Inherit Metab Dis; 2019 Nov 25; 42(6):1064-1076. PubMed ID: 30714172
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy for ornithine transcarbamylase deficiency.
    Kiwaki K, Matsuda I.
    Acta Paediatr Jpn; 1996 Apr 25; 38(2):189-92. PubMed ID: 8677801
    [Abstract] [Full Text] [Related]

  • 12. Retroviral-mediated gene transfer of human ornithine transcarbamylase into primary hepatocytes of spf and spf-ash mice.
    Grompe M, Jones SN, Loulseged H, Caskey CT.
    Hum Gene Ther; 1992 Feb 25; 3(1):35-44. PubMed ID: 1562638
    [Abstract] [Full Text] [Related]

  • 13. Molecular basis of ornithine transcarbamylase deficiency in spf and spf-ash mutant mice.
    Ohtake A, Takayanagi M, Yamamoto S, Kakinuma H, Nakajima H, Tatibana M, Mori M.
    J Inherit Metab Dis; 1986 Feb 25; 9(3):289-91. PubMed ID: 3099076
    [No Abstract] [Full Text] [Related]

  • 14. Restoration of hepatic cytochrome c oxidase activity and expression with acetyl-L-carnitine treatment in spf mice with an ornithine transcarbamylase deficiency.
    Mawal YR, Rama Rao KV, Qureshi IA.
    Biochem Pharmacol; 1998 Jun 01; 55(11):1853-60. PubMed ID: 9714304
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors.
    Brunetti-Pierri N, Clarke C, Mane V, Palmer DJ, Lanpher B, Sun Q, O'Brien W, Lee B.
    J Gene Med; 2008 Aug 01; 10(8):890-6. PubMed ID: 18563850
    [Abstract] [Full Text] [Related]

  • 16. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase.
    Nelson J, Qureshi IA, Vasudevan S, Sarma DS.
    Chem Biol Interact; 1993 Oct 01; 89(1):35-47. PubMed ID: 8221965
    [Abstract] [Full Text] [Related]

  • 17. Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery.
    Cunningham SC, Kok CY, Dane AP, Carpenter K, Kizana E, Kuchel PW, Alexander IE.
    Mol Ther; 2011 May 01; 19(5):854-9. PubMed ID: 21386824
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
    Li MX, Nakajima T, Fukushige T, Kobayashi K, Seiler N, Saheki T.
    Biochim Biophys Acta; 1999 Sep 20; 1455(1):1-11. PubMed ID: 10524224
    [Abstract] [Full Text] [Related]

  • 20. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice.
    Gushiken T, Yoshimura N, Saheki T.
    Biochem Int; 1985 Nov 20; 11(5):637-43. PubMed ID: 4091843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.